A new phase 1/2 clinical trial for an eye drop treatment for dry macular degeneration will begin shortly. MacuClear announced that it has entered into a collaborative business relationship with Mystic Pharmaceuticals. This agreement will advance the development of MC-1101, an eye drop treatment for dry macular degeneration (AMD). It is hoped that this eye drop treatment will help in the prevention of the progression of dry macular degeneration.
According to a press release issued by MacuClear, ““We believe Mystic’s novel VersiDoser™ delivery system will help overcome many of the challenges of topical delivery of ophthalmic drugs to the eye.”, said Philip G.Ralston, Jr., President and CEO of MacuCLEAR. “Standard eyedroppers typically deliver too large a drop that “floods” the eye. Conventional eyedroppers waste product and are difficult for elderly patients to use reliably on a daily basis.. Mystic’s individually packaged drops can be precisely sized and accurately delivered with a unique dispenser that is easy to use .” Ralston added, “the Mystic dispenser counts the drops delivered, which will be helpful in tracking compliance and accounting for the usage of a reimbursed product.”
In forming this collaborative arrangement, MacuClear has positioned itself in a unique opportunity to have its eye drops for dry macular degeneration approved by the FDA. This would be a novel treatment as most macular degeneration treatments must be injected directly into the eye. MacuClear hopes that by providing eye drops for dry macular degeneration, it will lessen stress on patients who suffer from macular degeneration.
In developing the eye drops for dry macular degeneration, MacuClear hopes to prevent the progression of dry macular degeneration to the wet form of the disease by preventing the rupture of the Bruch’s Membrane and by treating the aging effects of inflammation and oxidative stress.
With this announcement it is clear that there may be a viable treatment for dry macular degeneration in the near future. Having this an eye drop treatment for macular degeneration would be major.